BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23688840)

  • 21. The preparation and characterization of trans-platinum(IV) complexes with unusually high cytotoxicity.
    Cubo L; Hambley TW; Sanz Miguel PJ; Carnero A; Navarro-Ranninger C; Quiroga AG
    Dalton Trans; 2011 Jan; 40(2):344-7. PubMed ID: 20936210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel methylene modified cyclohexyl ethylenediamine-N,N'-diacetate ligands and their platinum(IV) complexes. Influence on biological activity.
    Mihajlović LE; Savić A; Poljarević J; Vučković I; Mojić M; Bulatović M; Maksimović-Ivanić D; Mijatović S; Kaluđerović GN; Stošić-Grujičić S; Miljković Đ; Grgurić-Šipka S; Sabo TJ
    J Inorg Biochem; 2012 Apr; 109():40-8. PubMed ID: 22369771
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Palladium(II) and platinum(II) bis(thiosemicarbazone) complexes of the 2,6-diacetylpyridine series with high cytotoxic activity in cisplatin resistant A2780cisR tumor cells and reduced toxicity.
    Matesanz AI; Leitao I; Souza P
    J Inorg Biochem; 2013 Aug; 125():26-31. PubMed ID: 23685347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and characterization of palladium(II) and platinum(II) complexes with Schiff bases derivatives of 2-pyridincarboxyaldehyde. Study of their interaction with DNA.
    García-Friaza G; Fernández-Botello A; Pérez JM; Prieto MJ; Moreno V
    J Inorg Biochem; 2006 Aug; 100(8):1368-77. PubMed ID: 16712937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug delivery with a calixpyrrole--trans-Pt(II) complex.
    Cafeo G; Carbotti G; Cuzzola A; Fabbi M; Ferrini S; Kohnke FH; Papanikolaou G; Plutino MR; Rosano C; White AJ
    J Am Chem Soc; 2013 Feb; 135(7):2544-51. PubMed ID: 23350677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platinum(II) and palladium(II) complexes with (N,N') and (C,N,N')- ligands derived from pyrazole as anticancer and antimalarial agents: synthesis, characterization and in vitro activities.
    Quirante J; Ruiz D; Gonzalez A; López C; Cascante M; Cortés R; Messeguer R; Calvis C; Baldomà L; Pascual A; Guérardel Y; Pradines B; Font-Bardía M; Calvet T; Biot C
    J Inorg Biochem; 2011 Dec; 105(12):1720-8. PubMed ID: 22104300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and structural characterization of copper(I) complexes bearing N-methyl-1,3,5-triaza-7-phosphaadamantane (mPTA): cytotoxic activity evaluation of a series of water soluble Cu(I) derivatives containing PTA, PTAH and mPTA ligands.
    Porchia M; Benetollo F; Refosco F; Tisato F; Marzano C; Gandin V
    J Inorg Biochem; 2009 Dec; 103(12):1644-51. PubMed ID: 19822369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploring nitrogen ligand diversity in trans-N-heterocyclic carbene-amine platinum complexes: synthesis, characterization, and application to fluorescence.
    Chardon E; Dahm G; Guichard G; Bellemin-Laponnaz S
    Chem Asian J; 2013 Jun; 8(6):1232-42. PubMed ID: 23559499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Three new asymmetric trans-amine(azole)dichloridoplatinum complexes that overcome cisplatin resistance and their reactions with 5'-GMP.
    Pantoja E; Gallipoli A; van Zutphen S; Komeda S; Reddy D; Jaganyi D; Lutz M; Tooke DM; Spek AL; Navarro-Ranninger C; Reedijk J
    J Inorg Biochem; 2006 Dec; 100(12):1955-64. PubMed ID: 17083978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis, characterization, and biological evaluation of new tetrazole-based platinum(II) and palladium(II) chlorido complexes--potent cisplatin analogues and their trans isomers.
    Serebryanskaya TV; Yung T; Bogdanov AA; Shchebet A; Johnsen SA; Lyakhov AS; Ivashkevich LS; Ibrahimava ZA; Garbuzenco TS; Kolesnikova TS; Melnova NI; Gaponik PN; Ivashkevich OA
    J Inorg Biochem; 2013 Mar; 120():44-53. PubMed ID: 23305964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The mechanism of action of platinum anticancer agents--what do we really know about it?
    Gibson D
    Dalton Trans; 2009 Dec; (48):10681-9. PubMed ID: 20023895
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of trans geometry in bifunctional mononuclear platinum complexes by a non-bulky methylamine ligand.
    Frybortova M; Novakova O; Stepankova J; Novohradsky V; Gibson D; Kasparkova J; Brabec V
    J Inorg Biochem; 2013 Sep; 126():46-54. PubMed ID: 23770803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sterically hindered complexes of platinum(II) with planar heterocyclic nitrogen donors. A novel complex with 1-methyl-cytosine has a spectrum of activity different from cisplatin and is able of overcoming acquired cisplatin resistance.
    Margiotta N; Natile G; Capitelli F; Fanizzi FP; Boccarelli A; De Rinaldis P; Giordano D; Coluccia M
    J Inorg Biochem; 2006 Nov; 100(11):1849-57. PubMed ID: 16959321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proteins as possible targets for cytotoxic trans-platinum(II) complexes with aliphatic amine ligands: Further exceptions to the DNA paradigm.
    Cubo L; Groessl M; Dyson PJ; Quiroga AG; Navarro-Ranninger C; Casini A
    ChemMedChem; 2010 Aug; 5(8):1335-43. PubMed ID: 20564276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytotoxicity of cis-platinum(II) cycloaliphatic amidine complexes: Ring size and solvent effects on the biological activity.
    Marzano C; Sbovata SM; Gandin V; Michelin RA; Venzo A; Bertani R; Seraglia R
    J Inorg Biochem; 2009 Aug; 103(8):1113-9. PubMed ID: 19560209
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antitumor effects of a tetradentate amido-carboxylate ligands and corresponding square-planar palladium(II) complexes toward some cancer cells. Crystal structure, DFT modeling and ligand to DNA probe docking simulation.
    Matović ZD; Mrkalić E; Bogdanović G; Kojić V; Meetsma A; Jelić R
    J Inorg Biochem; 2013 Apr; 121():134-44. PubMed ID: 23376555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A first-in-class and a fished out anticancer platinum compound: cis-[PtCl2(NH3)2] and cis-[PtI2(NH3)2] compared for their reactivity towards DNA model systems.
    Musumeci D; Platella C; Riccardi C; Merlino A; Marzo T; Massai L; Messori L; Montesarchio D
    Dalton Trans; 2016 May; 45(20):8587-600. PubMed ID: 27126508
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and antitumor activity of a series of osmium(VI) nitrido complexes bearing quinolinolato ligands.
    Tang Q; Ni WX; Leung CF; Man WL; Lau KK; Liang Y; Lam YW; Wong WY; Peng SM; Liu GJ; Lau TC
    Chem Commun (Camb); 2013 Nov; 49(85):9980-2. PubMed ID: 24042270
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis, characterization, and cytotoxicity of dinuclear platinum-bisphosphonate complexes to be used as prodrugs in the local treatment of bone tumours.
    Margiotta N; Ostuni R; Gandin V; Marzano C; Piccinonna S; Natile G
    Dalton Trans; 2009 Dec; (48):10904-13. PubMed ID: 20023921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An in vivo highly antitumor-active tetrazolato-bridged dinuclear platinum(II) complex largely circumvents in vitro cisplatin resistance: two linkage isomers yield the same product upon reaction with 9-ethylguanine but exhibit different cytotoxic profiles.
    Uemura M; Suzuki T; Nishio K; Chikuma M; Komeda S
    Metallomics; 2012 Jul; 4(7):686-92. PubMed ID: 22473092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.